Immunogenicity: The FDA classified BPC-157 in Category 2 for bulk drug substances, citing possible safety issues in compounding (immunogenicity, impurities, and insufficient safety evidence for suggested administration routes)
I can't-" Andrew Huberman: Or too much salt in there
Looking forward, the future of SFN research lies in well-designed, biomarker-stratified clinical trials that incorporate advanced formulations and consider the complex interplay between diet, host genetics, and gut microbiota
That's good then topazrat but keep your eye on it as it will "get used up" processing the B12
66, e0072122
362 Pomegranate-derived polyphenols alleviate RA by inhibiting the activation of MMP-13, simultaneously blocking the anti-inflammatory signaling pathway, and activating the antioxidant defense system in chondrocytes